This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Use of Thermal and 3D Imaging to Quantify Arthritis

This study has been completed.
Sponsor:
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01044823
First received: January 6, 2010
Last updated: July 26, 2017
Last verified: February 2011
  Purpose
One of the biggest challenges in caring for patients with Rheumatoid Arthritis (RA) and Juvenile Rheumatoid Arthritis (JRA) is quantifying the degree of disease activity in any given joint. We have built a prototype device using well-established sensors to rapidly quantify surface swelling and heat in arthritic joints. The goal of our studies is to test the hypothesis that this Imager can improve the clinical assessment of arthritis.

Condition Intervention
Rheumatoid Arthritis Juvenile Rheumatoid Arthritis Other: 3D and thermal imaging

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Use of Thermal and 3D Imaging to Quantify Arthritis

Resource links provided by NLM:


Further study details as provided by University of Pittsburgh:

Enrollment: 157
Study Start Date: January 2010
Study Completion Date: January 2014
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Adult RA Other: 3D and thermal imaging
subjects will be imaged before and after receiving DMARD therapy
pediatric JRA Other: 3D and thermal imaging
subjects will be imaged before and after receiving DMARD therapy

  Eligibility

Ages Eligible for Study:   4 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children with JRA adults with RA
Criteria

Inclusion Criteria:

  • at least 4 years of age

Exclusion Criteria:

  • less than 4 years of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01044823

Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224
Sponsors and Collaborators
University of Pittsburgh
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  More Information

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT01044823     History of Changes
Other Study ID Numbers: PRO08040135
R21AR056690 ( U.S. NIH Grant/Contract )
Study First Received: January 6, 2010
Last Updated: July 26, 2017

Keywords provided by University of Pittsburgh:
RA
JRA

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Arthritis, Juvenile
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on August 18, 2017